Cognitive Assessment

Selected news for the healthcare topic - Cognitive Assessment, collected since 10/2017. This healthcare topic shares news with COVID-19, Quest Diagnostics, Savonix, Digital Health and dozens of others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
1/21/2022 Cambridge Cognition (LON:COG) Stock Price Crosses Below 200 Day Moving Average of $146.01 - Mayfield Recorder Mayfield Recorder ... The company offers CANTAB Recruit, an online patient recruitment platform for pharmaceutical and biotechnology companies to identify qualified clinical trial participants in high-need indications, such as Alzheimer's disease; CANTAB Connect that provides digital cognitive assessment solutions for pharmaceutical clinical trials in various therapeutic areas from Phases IÂ-IV; and Cognition Kit, a digital health platform, which delivers wearable and smartphone apps for data collection to provide engaging digital ...
1/21/2022 Cambridge Cognition (LON:COG) Shares Cross Below 200 Day Moving Average of $146.01 - Slater Sentinel slatersentinel.com ... The company offers CANTAB Recruit, an online patient recruitment platform for pharmaceutical and biotechnology companies to identify qualified clinical trial participants in high-need indications, such as Alzheimer's disease; CANTAB Connect that provides digital cognitive assessment solutions for pharmaceutical clinical trials in various therapeutic areas from Phases IÂ-IV; and Cognition Kit, a digital health platform, which delivers wearable and smartphone apps for data collection to provide engaging digital ...
1/19/2022 Perfusion CT imaging as a diagnostic and prognostic tool for dementia: prospective case-control study BMJ ... we aimed to elucidate changes on cerebral perfusion CT (PCT) for early diagnosis of dementia; and to differentiate Alzheimer’s disease (AD) from vascular dementia (VaD). We also aimed to study correlation between Montreal Cognitive Assessment (MOCA) score and PCT parameters. Methods We conducted a prospective case–control study enrolling 25 dementia patients (15 cases of VaD, 10 cases of AD) and 25 age-matched controls. PCT was performed on ...
1/17/2022 Education level is a strong determinant of cognitive function as measured by MoCA in people with chronic low back pain. Physicians Weekly ... weight, height, education and pain duration. Pain intensity of the individuals was evaluated using the Visual Analog Scale, functional status was evaluated with the Oswestry Disability Index, and cognitive function was evaluated using Montreal Cognitive Assessment (MoCA).One hundred fifteen individuals with CLBP were recruited. The mean age was 48.4±11.8, and the mean MoCA score was 22.9±4.4. MoCA scores were associated with education, age, gender and pain intensity ...
1/15/2022 Cognitive Assessment and Training Market Updates, News and Data, Market Players : Cambridge Cognition, MedAvante-Prophase, Signant Health – 2022 – 2027 heraldkeeper.com Cognitive Assessment and Training Market Updates, News and Data, Market Players : Cambridge Cognition, MedAvante-Prophase, Signant Health – 2022 – 2027The Cognitive Assessment and Training Market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad. e regulations, recent developments, opportunities analysis, strategic market ...
1/10/2022 Cambridge Cognition announces new major pharma client for schizophrenia clinical trials directorstalkinterviews.com ... to assess the pro-cognitive effects of a new drug in schizophrenia. Together the contracts are worth £700,000 over two years. This is the second pharmaceutical client to award Cambridge Cognition major contracts for cognitive assessment s for schizophrenia in the last year1. Approximately 30 clinical trials on new drugs for schizophrenia run every year2, demonstrating the potential for further sales in this therapeutic area.Cambridge Cognition offers cognitive assessment s with ...
1/10/2022 Cambridge Cognition wins contracts for two clinical trials - Sharecast.com sharecast.com The AIM-traded firm said the contracts would be worth a combined £0.7m over two years.It was the second pharmaceutical client in the last year to award major contracts to the company for cognitive assessment s for schizophrenia.Around 30 clinical trials on new drugs for schizophrenia are run every year, the board said, demonstrating the potential for further sales in the therapeutic area.The company said the client had ...
1/10/2022 Cognivue Announces Partnership with American Institute of Balance to Expand Cognitive Screening hearinghealthmatters.org ... and ENT providers can go beyond their usual assessments to include the early detection of cognitive decline and follow-up education. We are grateful to AIB for recognizing the power and importance of having cognitive assessment become more widely available.”–Cognivue President and CEO, Tom O’NeillCognivue technologies are designed to give healthcare providers a useful tool for cognitive evaluation and diagnosis of various neurodegenerative and neuropsychological disorders ...
1/9/2022 Cambridge Cognition (LON:COG) Share Price Passes Below 200 Day Moving Average of $146.68 - Mayfield Recorder Mayfield Recorder ... The company offers CANTAB Recruit, an online patient recruitment platform for pharmaceutical and biotechnology companies to identify qualified clinical trial participants in high-need indications, such as Alzheimer's disease; CANTAB Connect that provides digital cognitive assessment solutions for pharmaceutical clinical trials in various therapeutic areas from Phases IÂ-IV; and Cognition Kit, a digital health platform, which delivers wearable and smartphone apps for data collection to provide engaging digital ...
1/9/2022 Cambridge Cognition (LON:COG) Shares Pass Below 200-Day Moving Average of $146.68 - Slater Sentinel slatersentinel.com ... The company offers CANTAB Recruit, an online patient recruitment platform for pharmaceutical and biotechnology companies to identify qualified clinical trial participants in high-need indications, such as Alzheimer's disease; CANTAB Connect that provides digital cognitive assessment solutions for pharmaceutical clinical trials in various therapeutic areas from Phases IÂ-IV; and Cognition Kit, a digital health platform, which delivers wearable and smartphone apps for data collection to provide engaging digital ...
1/8/2022 Cambridge Cognition (LON:COG) Stock Crosses Below 200 Day Moving Average of $146.68 zolmax.com ... The company offers CANTAB Recruit, an online patient recruitment platform for pharmaceutical and biotechnology companies to identify qualified clinical trial participants in high-need indications, such as Alzheimer's disease; CANTAB Connect that provides digital cognitive assessment solutions for pharmaceutical clinical trials in various therapeutic areas from Phases IÂ-IV; and Cognition Kit, a digital health platform, which delivers wearable and smartphone apps for data collection to provide engaging digital ...
1/7/2022 Dementia Tests "SAGE Tests" | U.S. News U.S. News & World Report ... who would administer an exam and evaluate the results. Today, anyone with a computer and access to a printer can in a matter of about 15 minutes take the four-page SAGE Test , a cognitive assessment tool developed by Dr. Douglas Scharre, director of the division of cognitive neurology at Ohio State University Wexner Medical Center . SAGE is an acronym for Self-Administered Gerocognitive Examination.[ See:8 Early Signs of ...
1/5/2022 Korean startup Looxid Labs wins CES 2022 Innovation Award in Health and Wellness koreatechdesk.com ... is meaningful for the company to receive this award four years after winning the CES 2018 best of innovation in VR/AR category.Looxid Labs has been recognized for its product ‘LUCY,’ a cognitive assessment and training system that uses AI and VR technologies to detect early signs of cognitive impairment, such as dementia and Alzheimer’s disease. LUCY has achieved outstanding recognition at the CES 2022 Innovation Awards ...
1/4/2022 Gray Matter Atrophy And Corresponding Impairments In Connectivity In Patients With Anti-N-Methyl-D-Aspartate Receptor Encephalitis researchsquare.com ... specific structural and functional alterations and their relationship with the clinical symptoms of anti-NMDAR encephalitis. In this study, twenty-two patients with anti-NMDAR encephalitis after the acute stage and 29 controls received cognitive assessment s and magnetic resonance imaging. Grey matter atrophy was measured using voxel-based morphometry, and functional alterations in abnormal regions were subsequently investigated using resting state functional connectivity (RSFC). Finally, correlation analyses were performed to ...
1/3/2022 Received the CES 2022 Innovation Awards in Health wapakdailynews.com ... it is meaningful for the company to receive this award four years after winning the CES 2018 best of innovation in VR/AR category.Looxid Labs has been recognized for its product 'LUCY,' a cognitive assessment and training system that uses AI and VR technologies to detect early signs of cognitive impairment, such as dementia and Alzheimer's disease. LUCY has achieved outstanding recognition at the CES 2022 Innovation Awards in ...
1/3/2022 Looxid Labs Wins a CES 2022 Innovation Award in Health and Globe Newswire ... it is meaningful for the company to receive this award four years after winning the CES 2018 best of innovation in VR/AR category.Looxid Labs has been recognized for its product 'LUCY,' a cognitive assessment and training system that uses AI and VR technologies to detect early signs of cognitive impairment, such as dementia and Alzheimer's disease. LUCY has achieved outstanding recognition at the CES 2022 Innovation Awards in ...
1/3/2022 Looxid Labs Wins a CES 2022 Innovation Award in Health and Wellness Yahoo News ... it is meaningful for the company to receive this award four years after winning the CES 2018 best of innovation in VR/AR category.Looxid Labs has been recognized for its product 'LUCY,' a cognitive assessment and training system that uses AI and VR technologies to detect early signs of cognitive impairment, such as dementia and Alzheimer's disease. LUCY has achieved outstanding recognition at the CES 2022 Innovation Awards in ...
1/3/2022 The Ridgway Record ridgwayrecord.com ... it is meaningful for the company to receive this award four years after winning the CES 2018 best of innovation in VR/AR category.Looxid Labs has been recognized for its product 'LUCY,' a cognitive assessment and training system that uses AI and VR technologies to detect early signs of cognitive impairment, such as dementia and Alzheimer's disease. LUCY has achieved outstanding recognition at the CES 2022 Innovation Awards in ...
1/3/2022 Biden “Failing at a Geometric Rate” richardcyoung.com ... 25th Amendment coup talk and went so low as to wheel out a Yale psychiatrist to claim Trump was crazy and needed an intervention removal. Their constant haranguing forced Trump to take the Montreal Cognitive Assessment —which he aced and which Joe Biden most assuredly will not take, nor will be encouraged to take.Apparently, Biden’s handlers believe in the next three years he can imitate the last few ...
1/1/2022 Cambridge Cognition (LON:COG) Shares Cross Above Fifty Day Moving Average of $128.64 - WKRB News wkrb13.com ... The company offers CANTAB Recruit, an online patient recruitment platform for pharmaceutical and biotechnology companies to identify qualified clinical trial participants in high-need indications, such as Alzheimer's disease; CANTAB Connect that provides digital cognitive assessment solutions for pharmaceutical clinical trials in various therapeutic areas from Phases IÂ-IV; and Cognition Kit, a digital health platform, which delivers wearable and smartphone apps for data collection to provide engaging digital ...